Ignite Creation Date:
2025-12-24 @ 6:31 PM
Ignite Modification Date:
2026-03-16 @ 2:24 AM
Study NCT ID:
NCT02455557
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-10-10
First Post:
2015-05-22
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
SurVaxM Vaccine Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma
Sponsor:
Roswell Park Cancer Institute
Organization: